In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report), with ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alkermes (ALKS – Research Report) today and set a price target of $36.00. The ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Criteo (NASDAQ:CRTO – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Stifel Nicolaus in a research note issued to investors on Thursday,Benzinga reports. They currently ...

Proficient Auto Logistics (NASDAQ:PAL – Get Free Report) had its price target decreased by investment analysts at Stifel Nicolaus from $15.00 to $14.00 in a report released on Thursday ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while ...

ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...

Jefferies LLC and Stifel, Nicolaus & Company, Incorporated served as financial advisors to ImaginAb on the transaction. About ImaginAb, Inc. ImaginAb, Inc. is a clinical stage, revenue-generating ...